Plasmid-mediated quinolone resistance – current knowledge and future perspectives

Journal of International Medical Research - Tập 41 Số 1 - Trang 20-30 - 2013
Xizhou Guan1, Xinying Xue2, Yuxia Liu3, Jing Wang2, Yong Wang2, Wang Jian-xin1, Kaifei Wang1, Hong Jiang2, Lina Zhang1, Bing Yang1, N Wang1, Lei Pan2
1Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
2Department of Special Medical Treatment – Respiratory Disease, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, China
3Research Department, Peking Union Medical Collage Hospital, Beijing, China

Tóm tắt

Quinolones are a group of antimicrobial agents that were serendipitously discovered as byproducts of the synthesis of chloroquine. Chemical modifications, such as the addition of fluorine or piperazine, resulted in the synthesis of third- and fourth-generation fluoroquinolones, with broad-spectrum antimicrobial actions against aerobic or anaerobic, Gram-positive or Gram-negative bacteria. The efficacy and consequent widespread use of quinolones and fluoroquinolones has led to a steady global increase in resistance, mediated via gene mutations, alterations in efflux or cell membranes and plasmid-conferred resistance. The first plasmid-mediated quinolone resistance gene, qnrA1, was detected in 1998. Since then, many other genes have been identified and the underlying mechanisms of resistance have been elucidated. This review provides an overview of quinolone resistance, with particular emphasis on plasmid-mediated resistance.

Từ khóa


Tài liệu tham khảo

10.1021/jm01240a021

10.1021/jm00398a003

10.1128/AAC.28.5.716

Brighty KE, Gootz TD: Chapter 2 – Chemistry and Mechanism of Action of the Quinolone Antibacterials. In: The Quinolones, 3rd edn (Andriole VT, ed). San Diego: Academic Press, 2000; pp 33–97.

10.1086/428050

10.1128/AAC.45.2.589-592.2001

10.1128/AAC.47.7.2327-2329.2003

10.1093/jac/dkg429

10.1128/.61.3.377-392.1997

10.1016/j.ijantimicag.2005.04.002

10.1093/jac/dkg207

10.1074/jbc.273.42.27668

Nicolle LE: Chapter 6 – Use of Quinolones in Urinary Tract Infection and Prostatitis. In: The Quinolones, 3rd edn (Andriole VT, ed). San Diego: Academic Press, 2000; pp 203–225.

10.2165/00003495-199958002-00010

Oliphant CM, 2002, Am Fam Physician, 65, 455

10.1056/NEJMra020201

10.1080/17843286.1996.11718508

10.1054/drup.1998.0068

10.1128/AAC.50.4.1178-1182.2006

10.1001/jama.289.7.885

10.1111/j.1469-0691.1999.tb00427.x

10.1128/AAC.45.5.1515-1521.2001

10.1128/JCM.42.4.1477-1482.2004

10.1093/jac/46.1.149

10.1016/S0140-6736(05)79356-9

10.3201/eid0706.010613

10.3201/eid0805.010288

10.1080/00365540410019039

NORM/NORM-VET Report 2006: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway (available at: http://www.vetinst.no/eng/Publications/Norm-Norm-Vet-Report).

10.1046/j.1365-2796.2002.01026.x

10.2165/00003495-199958002-00003

10.1128/AAC.45.8.2378-2380.2001

10.1128/JCM.40.11.4121-4125.2002

10.1093/jac/dkr566

10.1128/AAC.47.11.3567-3573.2003

10.1128/AAC.44.5.1223-1228.2000

10.1128/AAC.34.9.1715

10.1128/AAC.37.4.662

10.1099/00222615-46-7-623

10.1093/jac/42.6.683

10.1128/AAC.00147-08

10.1128/CMR.00016-09

10.1128/AAC.49.1.118-125.2005

10.1128/AAC.49.2.801-803.2005

10.1093/jac/dki245

10.1016/S1473-3099(06)70599-0

10.1086/505397

10.1093/jac/dkm283

10.1016/j.diagmicrobio.2007.10.002

10.1128/AAC.47.7.2242-2248.2003

10.1128/AAC.49.1.71-76.2005

10.1128/AAC.49.6.2522-2524.2005

10.1128/AAC.49.5.2146-2147.2005

10.1111/j.1469-0691.2006.01529.x

10.1128/AAC.00597-06

10.1128/AAC.00915-06

10.1111/j.1469-0691.2006.01389.x

10.1038/nm1347

10.1128/AAC.49.8.3523-3525.2005

10.1128/AAC.01616-06

10.1073/pnas.082092899

10.1128/AAC.48.4.1400-1401.2004

10.1093/jac/dki388

10.1128/AAC.01647-05

10.1128/AAC.00456-06

10.1093/jac/dkl213

10.1111/j.1745-7254.2008.00757.x

10.1128/AAC.00841-06

10.1093/jac/dkm261

10.1093/jac/dkm352

10.1093/jac/dkm448

10.1128/AAC.01082-06

10.1128/AAC.00378-06

10.1128/AAC.01042-07

10.1128/AAC.00293-06

10.1093/jac/dkq423